Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- In Exubera's Shadow: Generex Bets Oral Spray Is Next Big Thing for Diabetics
- In Exubera's Shadow: Generex Bets Oral Spray Is Next Big Thing for DiabeticsRE: In Exubera's Shadow: Generex Bets Oral Spray Is Next Big Thing for Diabetics..."What do you think?"...well, right now I think you are either one dumb, gullible SOB or else you're on GNBT's payroll...absorption of oralyn's insulin is...
- Discussion threads 2008-10-01
Additional Resources
- In Exubera's Shadow: Generex Bets Oral Spray Is Next Big Thing for Diabetics
- As companies bail out of the inhaled insulin business -- most recently Pfizer, which lost $2.8 billion before throwing Exubera overboard -- one small firm believes there is an alternative to pills, injections and inhalers. Generex, a Worcester, Mass.-based company, believes there's an opportunity for insulin delivery...
- Blog posts 2008-09-26
- MannKind Down to Its Last $28 Million; No Revenue in Sight
- MannKind Corp., which burns cash at a rate of $83 million and $75 million per quarter, has only $46.5 billion in current assets left. So it will have to borrow $350 million from Al Mann, the company chairman, to see itself through, according to Zack's. If you check out its...
- Blog posts 2009-02-20
- << Previous
- page 1 of 1
- Next >>
